News

Congratulations to Duke Neurosurgery residents Alexa Bramall, MD,PhD and Shervin Rahimpour, MD, who were named  2018-2019 Feagin Leadership Scholars.

Glioblastoma brain tumors can have an unusual effect on the body’s immune system, often causing a dramatic drop in the number of circulating T-cells that help drive the body’s defenses.

When Duke neurosurgeon Michael Haglund, MD, PhD, took his first humanitariam trip to Uganda 12 years ago, he says he "saw the need, and it was beyond great."

Results are being presented today at the International Conference on Brain Tumor Research and Therapy in Norway and published in The New England Journal of Medicine.

Duke neurosurgeon Isaac Karikari, MD, treats adults with scoliosis. Here he addresses four things you may not know about the condition.

After an extensive, nationwide search, the Duke departments of Neurosurgery and Orthopaedic Surgery are pleased to announce that Christopher I. Shaffrey, MD, FACS, will be the new chief of Duke's Spine Division, effective September 1, 2018.

Was it Alzheimer’s disease? Vertigo? Thelma Cooper didn’t know what was causing her blackouts, memory lapses, and debilitating nausea, and the lack of answers drove her into a depression.

Lisa VanTress didn’t know why she couldn’t regain her land legs after a 13-hour fishing trip in the summer of 2016.

Most glioblastoma tumors are marked by one or two broad mutation patterns, but about 20 percent of the lethal brain tumors have biomarkers that cannot be identified.